Adalimumab rapidly induces clinical remission and response in patients with moderate to severe Crohn's disease who had secondary failure to infliximab therapy: Results of the GAIN study

被引：9
|
作者：
Sandborn, William J.
Rutgeerts, P.
Enns, R. A.
Hanauer, S. B.
Colombel, J. F.
Panaccione, R.
Kent, J. D.
Pollack, P. F.
机构：
[1] Mayo Clin Rochester, Rochester, MN USA
[2] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
[3] St Pauls Hosp, Pacif Gastroenterol Assoc, Vancouver, BC V6Z 1Y6, Canada
[4] Univ Chicago, Chicago, IL 60637 USA
[5] CHU Lille, F-59037 Lille, France
[6] Univ Calgary, Inflammatory Bowel Dis Clin, Calgary, AB, Canada
[7] Immunol Dev, Abbott Pk, IL USA
[8] Immunol Dev, Parsippany, NJ USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2006年 / 101卷 / 09期
关键词：
D O I：
10.14309/00000434-200609001-01147
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1147
引用
收藏
页码：S448 / S448
页数：1
相关论文
共 50 条
  • [1] Rapid induction of remission and clinical response with adalimumab in patients with moderate to severe Crohn's disease and secondary failure to infliximab therapy: Results of the gain studya
    Columbel, J.
    Rutgeerts, P.
    Sandborn, W. J.
    Enns, R.
    Hanauer, S. B.
    Kent, J. D.
    Pollack, P. F.
    [J]. GUT, 2007, 56 : A109 - A109
  • [2] Remission and clinical response to adalimumab at 4 weeks in patients with active luminal Crohn's disease who had lost response to or were intolerant of infliximab therapy
    Hinojosa, Joaquin
    Garcia, S.
    Esteve, M.
    Garcia, V.
    Martinez, P.
    Obrador, A.
    Gassull, M. A.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S455 - S456
  • [3] Certolizumab Pegol in Patients With Moderate to Severe Crohn's Disease and Secondary Failure to Infliximab
    Sandborn, William J.
    Abreu, Maria T.
    D'Haens, Geert
    Colombel, Jean-Frederic
    Vermeire, Severine
    Mitchev, Krassimir
    Jamoul, Corinne
    Fedorak, Richard N.
    Spehlmann, Martina E.
    Wolf, Douglas C.
    Lee, Scott
    Rutgeerts, Paul
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (08) : 688 - 695
  • [4] Clinical Response to Infliximab after Secondary Failure with Adalimumab or Certolizumab Pegol in Crohn's Disease
    Trivella, Juan
    Yarur, Andres
    Moroney, James
    Deshpande, Amar
    Abreu, Maria
    Sussman, Daniel
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S560 - S561
  • [5] Efficacy of adalimumab in patients with Crohn's disease and failure to infliximab therapy: a clinical series
    Cordero Ruiz, Patricia
    Castro Marquez, Cristina
    Mendez Rufian, Vanesa
    Castro Laria, Luisa
    Caunedo Alvarez, Angel
    Romero Vazquez, Javier
    Herrerias Gutierrez, Juan Manuel
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2011, 103 (06) : 294 - 298
  • [6] Adalimumab induces and maintains clinical response and remission in patients with active Crohn's disease: Results of the CHARM Trial
    Colombel, J.
    Sandborn, W. J.
    Rutgeerts, P.
    Enns, R.
    Hanauer, S. B.
    Remo, P.
    Schreiber, S.
    Lomax, K. G.
    Pollack, P. F.
    [J]. GASTROENTEROLOGY, 2006, 131 (03) : 950 - 950
  • [7] Adalimumab Therapy for Patients With Crohn's Disease Who Are Unresponsive to or Intolerant of Infliximab
    Shafran, I
    Burgunder, P.
    Fakih, A.
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S44 - S44
  • [8] Adalimumab Treatment Results in Deep Remission for Patients With Moderate to Severe Ileocolonic Crohn's Disease: Results From EXTEND
    Colombel, Jean-Frederic
    Rutgeerts, Paul J.
    Sandborn, William J.
    Camez, Anne A.
    Pollack, Paul F.
    Chen, Naijun
    Yang, Mei
    Mulani, Parvez
    Chao, Jingdong
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S518 - S518
  • [9] Comparative study of infliximab and adalimumab induction therapy for clinical remission and mucosal healing in paediatric patients with active Crohn's disease
    Szymanska, E.
    Dadalski, M.
    Szymanska, S.
    Grajkowska, W.
    Pronicki, M.
    Jaroslaw, K.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S290 - S290
  • [10] Sustained steroid-free clinical remission in patients with moderate to severe Crohn's disease treated with adalimumab
    Hanauer, Stephen B.
    Kaam, M. A.
    Colombel, J. F.
    Sandborn, W. J.
    Rutgeerts, P.
    Kent, J. D.
    Pollack, P. F.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S460 - S460
12345